Results 1 to 10 of about 291,220 (220)
Background: This study was designed to determine the prevalence and assess the risk factors responsible for platelet transfusion refractoriness in hemato-oncological patients. Materials and Methods: The study included 30 patients.
Vijay Kumawat +3 more
doaj +2 more sources
[Objective] To compare and analyze the efficacy of platelet transfusion in patients with different doses, and to analyze the risk factors for platelet transfusion refractoriness.
ZHU Jianling +5 more
doaj +2 more sources
Prevalence of platelet reactive antibodies in patient′s refractory to platelet transfusions
Introduction & Aims: Though platelet transfusions have greatly reduced the incidence of major haemorrhagic complications associated with the management of haematological and oncological disorders, refractoriness to infused platelets becomes a major ...
Nitin Agarwal +3 more
doaj +2 more sources
Predictors of Corrected Count Increment after Pooled Platelet Concentrate Transfusion in Thrombocytopenic Patients: A Cohort Study [PDF]
Introduction: Platelet transfusion is essential in managing thrombocytopenic patients to prevent or control bleeding. Corrected Count Increment (CCI) is a key measure of transfusion efficacy.
Sushree Sumedha Dash +2 more
doaj +2 more sources
Efficacy of apheresis platelet transfusion in 310 patients with haematological diseases
Objective To observe the effect of platelet transfusion in inpatients with haematological diseases, analyze the possible causes of platelet transfusion refractoriness (PTR), in order to further improve the efficacy of platelet transfusion.
Shisong YOU +5 more
doaj +1 more source
Platelet Transfusion Refractoriness
Platelet transfusion refractoriness (PTR) is a conditioikb1n where platelet counts fail to increase adequately in several transfusions, often found in hemato-oncological situations.
Anna Mira Lubis MD +2 more
doaj +1 more source
Introduction: Microvascular endothelial damage is a well-recognized complication of bone marrow transplantation (BMT) and the mechanisms of this disorder are still poorly understood.
Victor Quinet de Andrade Bastos +4 more
doaj +1 more source
[Objective] To evaluate the performance of platelet efficacy score (PEscore) in predicting platelet transfusion efficacy in hematological patients. [Methods] A total of 485 patients with hematological diseases, including 298 males (62.09±15.45 years) and
LI Jun +4 more
doaj +1 more source
A mini-review on platelet refractoriness
BACKGROUND: Lack of adequate post-transfusion platelet count increments - platelet refractoriness - is a complication of chronic platelet support shown by 5-15% of chronic platelet recipients. INFORMATION SOURCES.
P Rebulla
doaj
Patients with thrombocytopenia or platelet dysfunction often require platelet transfusions to improve their condition. However, some patients develop platelet transfusion refractoriness (PTR) after multiple transfusions, characterized by a lack of ...
Clinical Transfusion Medicine Professional Committee of the Chinese Society of Blood Transfusion
doaj +1 more source

